Testing effectiveness (Phase 2)Study completedNCT01541280
What this trial is testing
VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Nantes University Hospital 30